POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,864 | +96.2% | 783,071 | +45.0% | 0.00% | +200.0% |
| Q2 2023 | $950 | -48.9% | 540,024 | -10.5% | 0.00% | -50.0% |
| Q1 2023 | $1,858 | +78.7% | 603,200 | +207.3% | 0.00% | +100.0% |
| Q4 2022 | $1,040 | -99.9% | 196,300 | -42.8% | 0.00% | -50.0% |
| Q3 2022 | $1,212,000 | +23.5% | 343,300 | -9.7% | 0.00% | +100.0% |
| Q2 2022 | $981,000 | +17.1% | 380,100 | +103.3% | 0.00% | 0.0% |
| Q1 2022 | $838,000 | +265.9% | 187,000 | +456.5% | 0.00% | – |
| Q4 2021 | $229,000 | +143.6% | 33,600 | +160.5% | 0.00% | – |
| Q3 2021 | $94,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |